Biotech is driving scientific breakthroughs that were once unimaginable. However, Jeremy Levin, a veteran executive in the industry, warns that while the future of biotech looks promising, the institutions supporting these innovations—ranging from regulators and investors to the broader public—face significant challenges that could jeopardize America’s leadership in the field.
Back
